BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
KLK3
,
Apoptosis
,
Inflammatory disorder
,
Prostate
,
Aspirin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
nuclear receptor binding
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Skeletal muscle
Whole brain
Ovary
Pancreas
Vagina
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Multiple-resistant Staphylococcus aureus infection
Alpha-1-antitrypsin deficiency
Disorder of digestive system
Antiphospholipid syndrome
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
CGP 60474
CP 724714
AT 7519
flavopiridol
OTS-167
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
hsa-miR-365a-3p
EFCAB2
DROSHA
NRF1
MIR122
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Motor neuron MNEU.E cells treated with small molecule perturbagens
L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for nuclear receptor binding
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation
I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers
I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD
Normal Binding of R-[11C]PK11195 in Human Subjects
NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ